• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用非病毒、非整合的附加体自杀构建体保护多能干细胞用于细胞治疗。

Safeguarding pluripotent stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct.

机构信息

Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.

出版信息

Biomaterials. 2012 Oct;33(29):7261-71. doi: 10.1016/j.biomaterials.2012.06.038. Epub 2012 Jul 12.

DOI:10.1016/j.biomaterials.2012.06.038
PMID:22795541
Abstract

Pluripotent stem cells provide an unlimited cell source for cell therapy. However, residual pluripotent stem cells after differentiation can form tumors. Modifying stem cells with suicide constructs through integrating plasmid DNA and viral vectors has been attempted to specifically eliminate residual pluripotent stem cells after differentiation. However, integration of foreign DNA has the potential of insertional mutagenesis, position effects and silencing. Scaffold/matrix attachment region (S/MAR)-based plasmid DNA can be maintained extra-chromosomally, offering a safer alternative to integrating vectors for this purpose. Here, we report the design of an S/MAR-based suicide construct capable of episomal maintenance and specifically killing pluripotent stem cells but not differentiated cells in the presence of ganciclovir. Treating cells differentiated from episomal suicide construct-modified stem cells with ganciclovir reduces the tumor formation risk after cell transplantation. Tumors formed by such modified pluripotent stem cells could be inhibited by ganciclovir administration. This episomal suicide construct enables negative selection of residual pluripotent stem cells in vitro and control of tumors formed from residual pluripotent stem cells in vivo.

摘要

多能干细胞为细胞治疗提供了无限的细胞来源。然而,分化后的残留多能干细胞可能会形成肿瘤。通过整合质粒 DNA 和病毒载体,用自杀构建物修饰干细胞,已尝试专门消除分化后残留的多能干细胞。然而,外源 DNA 的整合具有插入突变、位置效应和沉默的潜在风险。基于支架/基质附着区 (S/MAR) 的质粒 DNA 可以在染色体外维持,为该目的提供了比整合载体更安全的替代方案。在这里,我们报告了一种基于 S/MAR 的自杀构建物的设计,该构建物能够在存在更昔洛韦的情况下进行附加体维持,并特异性杀死多能干细胞,但不杀死分化细胞。用更昔洛韦处理来自附加体自杀构建物修饰的干细胞分化的细胞可降低细胞移植后形成肿瘤的风险。用更昔洛韦治疗可抑制此类修饰的多能干细胞形成的肿瘤。这种附加体自杀构建物可在体外进行残留多能干细胞的负选择,并控制体内由残留多能干细胞形成的肿瘤。

相似文献

1
Safeguarding pluripotent stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct.用非病毒、非整合的附加体自杀构建体保护多能干细胞用于细胞治疗。
Biomaterials. 2012 Oct;33(29):7261-71. doi: 10.1016/j.biomaterials.2012.06.038. Epub 2012 Jul 12.
2
Selective ablation of human embryonic stem cells expressing a "suicide" gene.对表达“自杀”基因的人类胚胎干细胞进行选择性消融。
Stem Cells. 2003;21(3):257-65. doi: 10.1634/stemcells.21-3-257.
3
Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.非病毒 S/MAR 载体在提供选择优势时会在体内以附加体形式复制。
Gene Ther. 2011 Jan;18(1):82-7. doi: 10.1038/gt.2010.116. Epub 2010 Aug 26.
4
Suicide gene-mediated ablation of tumor-initiating mouse pluripotent stem cells.自杀基因介导的肿瘤起始性小鼠多能干细胞消融。
Biomaterials. 2013 Feb;34(6):1701-11. doi: 10.1016/j.biomaterials.2012.11.018. Epub 2012 Dec 4.
5
Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.基于S/MAR元件的复制型附加型载体中HBB转基因表达的生理水平。
J Biotechnol. 2009 Aug 20;143(2):85-94. doi: 10.1016/j.jbiotec.2009.06.018. Epub 2009 Jun 25.
6
Use of the cytomegalovirus promoter for transient and stable transgene expression in mouse embryonic stem cells.巨细胞病毒启动子在小鼠胚胎干细胞中用于瞬时和稳定转基因表达的应用。
Methods Mol Biol. 2006;329:283-94. doi: 10.1385/1-59745-037-5:283.
7
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.诱导多能干细胞(iPS细胞)诱导过程中的逆转录病毒载体沉默:一种指示不同多能状态的表观遗传信号。
J Cell Biochem. 2008 Nov 1;105(4):940-8. doi: 10.1002/jcb.21912.
8
Scaffold/matrix attached region-based nonviral episomal vectors.支架/基质附着的基于区域的非病毒附加型染色体外载体。
Hum Gene Ther. 2011 Aug;22(8):915-23. doi: 10.1089/hum.2011.084. Epub 2011 Jul 27.
9
In vitro differentiation of reprogrammed murine somatic cells into hepatic precursor cells.重编程的小鼠体细胞在体外分化为肝前体细胞。
Biol Chem. 2008 Jul;389(7):889-96. doi: 10.1515/BC.2008.107.
10
Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.在NOD/SCID小鼠中,用携带人凝血因子VIII基因的基于猿猴免疫缺陷病毒agmTYO1的载体转导的人脐血来源的CD34+细胞实现持续的转基因表达。
J Gene Med. 2004 Oct;6(10):1049-60. doi: 10.1002/jgm.609.

引用本文的文献

1
Elimination of tumorigenic pluripotent stem cells from their differentiated cell therapy products: An important step toward ensuring safe cell therapy.从其分化的细胞治疗产品中消除致瘤性多能干细胞:迈向确保细胞治疗安全的重要一步。
Stem Cell Reports. 2025 Jul 8;20(7):102543. doi: 10.1016/j.stemcr.2025.102543. Epub 2025 Jun 19.
2
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy.诱导多能干细胞来源的基于抗原呈递细胞的癌症免疫疗法安全性的提高。
Mol Ther Methods Clin Dev. 2021 Mar 5;21:171-179. doi: 10.1016/j.omtm.2021.03.002. eCollection 2021 Jun 11.
3
Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.
基于人多能干细胞的神经退行性疾病治疗:现状与挑战。
Cells. 2020 Nov 20;9(11):2517. doi: 10.3390/cells9112517.
4
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.脊髓损伤后源自人诱导多能干细胞的神经干细胞/祖细胞移植的肿瘤发生细胞的选择性清除。
Stem Cells Transl Med. 2019 Mar;8(3):260-270. doi: 10.1002/sctm.18-0096. Epub 2018 Nov 28.
5
Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.诱导多能干细胞衍生物移植后防止潜在致瘤性的故障安全系统。
Stem Cell Reports. 2017 Mar 14;8(3):673-684. doi: 10.1016/j.stemcr.2017.02.003. Epub 2017 Mar 2.